371 related articles for article (PubMed ID: 30019285)
1. Technical feasibility, radiation dosimetry and clinical use of
Usmani S; Van den Wyngaert T; Ahmed N; Marafi F; Esmail A; Al Kandari F; Al Nuaimi M; Gnanasegaran G
Ann Nucl Med; 2018 Nov; 32(9):594-601. PubMed ID: 30019285
[TBL] [Abstract][Full Text] [Related]
2. Novel weight-based dose threshold for 18F-NaF PET-CT imaging using advanced PET-CT systems: a potential tool for reducing radiation burden.
Marafi F; Esmail A; Rasheed R; Alkandari F; Usmani S
Nucl Med Commun; 2017 Sep; 38(9):764-770. PubMed ID: 28723715
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Challenge of Staging Metastatic Bone Disease in the Morbidly Obese Patients: A Primary Study Evaluating the Usefulness of 18F-Sodium Fluoride (NaF) PET-CT.
Usmani S; Marafi F; Ahmed N; Esmail A; Al Kandari F; Van den Wyngaert T
Clin Nucl Med; 2017 Nov; 42(11):829-836. PubMed ID: 28872551
[TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of (99m)Tc MDP scintigraphy, (18)F NaF PET/CT, and (18)F FDG PET/CT for detection of skeletal metastases.
Iagaru A; Mittra E; Dick DW; Gambhir SS
Mol Imaging Biol; 2012 Apr; 14(2):252-9. PubMed ID: 21479710
[TBL] [Abstract][Full Text] [Related]
5.
Langsteger W; Rezaee A; Pirich C; Beheshti M
Semin Nucl Med; 2016 Nov; 46(6):491-501. PubMed ID: 27825429
[No Abstract] [Full Text] [Related]
6.
Wondergem M; van der Zant FM; Knol RJJ; Burgers AMG; Bos SD; de Jong IJ; Pruim J
World J Urol; 2018 Jan; 36(1):27-34. PubMed ID: 29043431
[TBL] [Abstract][Full Text] [Related]
7. A Prospective Study Comparing
Löfgren J; Mortensen J; Rasmussen SH; Madsen C; Loft A; Hansen AE; Oturai P; Jensen KE; Mørk ML; Reichkendler M; Højgaard L; Fischer BM
J Nucl Med; 2017 Nov; 58(11):1778-1785. PubMed ID: 28798033
[TBL] [Abstract][Full Text] [Related]
8. A proof-of-concept study analyzing the clinical utility of fluorine-18-sodium fluoride PET-CT in skeletal staging of oncology patients with end-stage renal disease on dialysis.
Usmani S; Marafi F; Esmail A; Ahmed N
Nucl Med Commun; 2017 Dec; 38(12):1067-1075. PubMed ID: 28953207
[TBL] [Abstract][Full Text] [Related]
9. The Role of 18F-Sodium Fluoride PET/CT Bone Scans in the Diagnosis of Metastatic Bone Disease from Breast and Prostate Cancer.
Kulshrestha RK; Vinjamuri S; England A; Nightingale J; Hogg P
J Nucl Med Technol; 2016 Dec; 44(4):217-222. PubMed ID: 27634981
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients.
Yen RF; Chen CY; Cheng MF; Wu YW; Shiau YC; Wu K; Hong RL; Yu CJ; Wang KL; Yang RS
Nucl Med Commun; 2010 Jul; 31(7):637-45. PubMed ID: 20389259
[TBL] [Abstract][Full Text] [Related]
11.
Sheikhbahaei S; Jones KM; Werner RA; Salas-Fragomeni RA; Marcus CV; Higuchi T; Rowe SP; Solnes LB; Javadi MS
Ann Nucl Med; 2019 May; 33(5):351-361. PubMed ID: 30877561
[TBL] [Abstract][Full Text] [Related]
12. Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design.
Gerety EL; Lawrence EM; Wason J; Yan H; Hilborne S; Buscombe J; Cheow HK; Shaw AS; Bird N; Fife K; Heard S; Lomas DJ; Matakidou A; Soloviev D; Eisen T; Gallagher FA
Ann Oncol; 2015 Oct; 26(10):2113-8. PubMed ID: 26202597
[TBL] [Abstract][Full Text] [Related]
13. Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases.
Iagaru A; Young P; Mittra E; Dick DW; Herfkens R; Gambhir SS
Clin Nucl Med; 2013 Jul; 38(7):e290-6. PubMed ID: 23455520
[TBL] [Abstract][Full Text] [Related]
14. Early experience with fluorine-18 sodium fluoride bone PET in young patients with back pain.
Lim R; Fahey FH; Drubach LA; Connolly LP; Treves ST
J Pediatr Orthop; 2007; 27(3):277-82. PubMed ID: 17414009
[TBL] [Abstract][Full Text] [Related]
15. Intra-individual comparison of
Bénard F; Harsini S; Wilson D; Zukotynski K; Abikhzer G; Turcotte E; Cossette M; Metser U; Romsa J; Martin M; Mar C; Saad F; Soucy JP; Eigl BJ; Black P; Krauze A; Burrell S; Nichol A; Tardif JC
Lancet Oncol; 2022 Dec; 23(12):1499-1507. PubMed ID: 36343655
[TBL] [Abstract][Full Text] [Related]
16. Prospective comparative study of
Fonager RF; Zacho HD; Langkilde NC; Fledelius J; Ejlersen JA; Hendel HW; Haarmark C; Moe M; Mortensen JC; Jochumsen MR; Petersen LJ
Acta Oncol; 2018 Aug; 57(8):1063-1069. PubMed ID: 29447047
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of 18F-NaF PET/CT in bone metastasis detection and its effect on patient management in patients with breast carcinoma.
Broos WAM; van der Zant FM; Wondergem M; Knol RJJ
Nucl Med Commun; 2018 Apr; 39(4):325-333. PubMed ID: 29351123
[TBL] [Abstract][Full Text] [Related]
18. Newer PET application with an old tracer: role of 18F-NaF skeletal PET/CT in oncologic practice.
Bastawrous S; Bhargava P; Behnia F; Djang DS; Haseley DR
Radiographics; 2014; 34(5):1295-316. PubMed ID: 25208282
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Bone Metastases between
Wang D; Yang Y; Zeng Z; Ye J; Guo C; Huang S; Guo X; Xiao J
Contrast Media Mol Imaging; 2022; 2022():5975338. PubMed ID: 35494210
[TBL] [Abstract][Full Text] [Related]
20. Molecular imaging in oncology: (18)F-sodium fluoride PET imaging of osseous metastatic disease.
Mick CG; James T; Hill JD; Williams P; Perry M
AJR Am J Roentgenol; 2014 Aug; 203(2):263-71. PubMed ID: 25055258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
